Robotic Minimally Invasive Ventral Hernia Repair With DEXTER

NCT ID: NCT07071740

Last Updated: 2026-01-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

33 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-06-11

Study Completion Date

2026-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this clinical investigation is to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing incisional or primary ventral hernia repair.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ventral Hernia Repair

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ventral hernia repair

Robotic-assisted incisional or primary ventral hernia repair with the DEXTER robotic surgery system

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged \> 18 years
* Planned to undergo incisional and primary midline ventral (M2-M4; epigastric, umbilical and infraumbilical) hernia repair smaller and equal to 8cm
* Patient agrees to perform the 30-day follow-up assessment, as per standard of care

Exclusion Criteria

* Any planned concomitant procedures
* Active anticoagulant treatment
* Recurring hernia with mesh during primary hernia repair
* Need for transversal abdominal release
* Patients under corticosteroids or other immunosuppressive treatment
* Loss of domain type of hernia
* Previous incision extending from xiphoid process to pubic bone (= Median laparotomy M1 to M5)
* M2 hernia extending to M1 and/or M4 hernia extending to M5
* Ongoing intra-abdominal infection or septic state
* Abdominal fistulae
* History of major\* abdominal or pelvic surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Confinis

INDUSTRY

Sponsor Role collaborator

Distalmotion SA

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Allgemein öffentliches Krankenhaus Spittal/Drau

Spittal an der Drau, , Austria

Site Status

GH Saintes - Saint-Jean-d'Angély Site de Saintes

Saintes, , France

Site Status

Artemed Klinikum München Süd

München, , Germany

Site Status

Kantonsspital Winterthur

Winterthur, , Switzerland

Site Status

Hirslanden Klinik Zürich

Zurich, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria France Germany Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hernia Repair in Multiply Morbid Patients
NCT00930787 TERMINATED PHASE4
Antimicrobial Hernia Repair Device
NCT02730936 WITHDRAWN NA